Baxion
Screening
Tags
Alerts
Theme
Xeris Biopharma Holdings, Inc.
XERS
·
NASDAQ
·
$6.26
Share Price as of 11/2
·
$1B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
03/02/26
10-Q
Q3 ended 09/30/25
11/06/25
10-Q
Q2 ended 06/30/25
08/07/25
Disclosures
Filter
8-K
Change in Directors or Officers; Regulation FD Disclosure
11/02/26
8-K
Current report
10/14/26
8-K
Current report
09/09/26
8-K
Results of Operations
08/06/26
8-K
Unregistered Sales of Equity; Other Events
07/17/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
03/02/26
S-3
Shelf registration
03/06/25
S-8
Registration of securities for employees
03/06/25
S-8
Registration of securities for employees
08/08/24
S-8
Registration of securities for employees
03/06/24
Proxies
Filter
DEF 14A
Definitive proxy
04/23/26
DEFA14A
Additional proxy materials
04/23/26
DEF 14A
Definitive proxy
04/23/25
DEFA14A
Additional proxy materials
04/23/25
DEF 14A
Definitive proxy
04/23/24
Ownership
Filter
Form 4
Insider transaction
10/02/26
Form 4
Insider transaction
10/02/26
Form 4
Insider transaction
10/02/26
144
Proposed sale of securities
10/01/26
Form 4
Insider transaction
09/29/26
Other
Filter
ARS
Annual report to shareholders
04/23/26
EFFECT
Request for effectiveness
05/13/25
CORRESP
Correspondence with the SEC
05/09/25
ARS
Annual report to shareholders
04/23/25
UPLOAD
Letter from the SEC
03/11/25
Latest Filings
Filter
8-K
Change in Directors or Officers; Regulation FD Disclosure
11/02/26
8-K
Current report
10/14/26
8-K
Current report
09/09/26
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Results of Operations
08/06/26
Ownership
Filter
Form 4
Insider transaction
10/02/26
Form 4
Insider transaction
10/02/26
Form 4
Insider transaction
10/02/26
144
Proposed sale of securities
10/01/26
Form 4
Insider transaction
09/29/26